{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:49:36Z","timestamp":1767494976804,"version":"3.40.5"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T00:00:00Z","timestamp":1529539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ijcha.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T04:58:46Z","timestamp":1530334726000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Antithrombotic therapy in ventricular assist device (VAD) management: From ancient beliefs to updated evidence. A narrative review"],"prefix":"10.1016","volume":"20","author":[{"given":"Nuccia","family":"Morici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Varrenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Perna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0632-0561","authenticated-orcid":false,"given":"Manlio","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1676-5257","authenticated-orcid":false,"given":"Enrico","family":"Ammirati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Frigerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7343-4534","authenticated-orcid":false,"given":"Marco","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2018.06.005_bb0005","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0015","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","article-title":"EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0020","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.healun.2014.02.014","article-title":"A contemporary review of mechanical circulatory support","volume":"33","author":"Patel","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0025","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jchf.2015.05.011","article-title":"The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies","volume":"3","author":"Teuteberg","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0030","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.healun.2017.07.005","article-title":"Eighth annual INTERMACS report: special focus on framing the impact of adverse events","volume":"36","author":"Kirklin","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0035","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jchf.2017.02.016","article-title":"Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: the ROADMAP study 2-year results","volume":"5","author":"Starling","year":"2017","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.healun.2014.04.010","article-title":"Sixth INTERMACS annual report: a 10,000-patient database","volume":"33","author":"Kirklin","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jchf.2014.11.008","article-title":"Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System","volume":"4","author":"Goldstein","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0050","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.jacc.2016.03.573","article-title":"Diagnosis and treatment algorithm for blood flow obstructions in patients with left ventricular assist device","volume":"67","author":"Scandroglio","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0055","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/STROKEAHA.116.014049","article-title":"Stroke risk and mortality in patients with ventricular assist devices","volume":"47","author":"Parikh","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1525-1594.2012.01567.x","article-title":"Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device","volume":"37","author":"Muthiah","year":"2013","journal-title":"Artif. Organs"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0065","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.jtcvs.2011.12.035","article-title":"HeartWare continuous-flow ventricular assist device thrombosis: the Bad Oeynhausen experience","volume":"143","author":"Aissaoui","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2018.0522","article-title":"Evolution of left ventricle assist device therapy for advanced heart failure. A review","author":"Miller","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0075","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.healun.2018.03.002","article-title":"Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study","volume":"37","author":"Netuka","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0080","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1161\/CIRCULATIONAHA.117.028303","article-title":"Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6\u202fmonths: a randomized controlled study of a fully magnetically levitated pump in advanced heart failure","volume":"135","author":"Uriel","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0085","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V88.5.1525.1525","article-title":"Platelets and shear stress","volume":"88","author":"Kroll","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0090","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0095","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0079-6107(02)00052-4","article-title":"Fluid shear stress and the vascular endothelium: for better and for worse","volume":"81","author":"Resnick","year":"2003","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0105","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1182\/blood.V88.8.2939.bloodjournal8882939","article-title":"Shear-dependent changes in the three-dimensional structure of human von Willebrand factor","volume":"88","author":"Siedlecki","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1083\/jcb.200609004","article-title":"Alpha v beta3 and alpha5beta1 integrin recycling pathways dictate downstream Rho kinase signaling to regulate persistent cell migration","volume":"177","author":"White","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0115","doi-asserted-by":"crossref","first-page":"11205","DOI":"10.1073\/pnas.172161899","article-title":"Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo","volume":"99","author":"Lobov","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0120","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1158\/0008-5472.CAN-09-1977","article-title":"Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth","volume":"70","author":"Hashizume","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0125","doi-asserted-by":"crossref","first-page":"23842","DOI":"10.1074\/jbc.M109.097543","article-title":"Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradation","volume":"285","author":"Thomas","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1097\/MAT.0000000000000745","article-title":"Numerical investigation of the influence of blade radial gap flow on axial blood pump performance","author":"Liu","year":"2018","journal-title":"ASAIO J."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0135","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1525-1594.2007.00422.x","article-title":"Numerical simulation of an axial blood pump","volume":"31","author":"Chua","year":"2007","journal-title":"Artif. Organs"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0140","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/jth.13044","article-title":"Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear-induced platelet activation","volume":"13","author":"Herbig","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0145","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/196476a0","article-title":"Effect of adsorbed proteins on the wettability of hydrophilic and hydrophobicsolids","volume":"196","author":"Vroman","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jtcvs.2014.09.031","article-title":"Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage","volume":"149","author":"Bartoli","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MAT.0b013e318283815c","article-title":"Mechanistic pathway(s) of acquired von Willebrand syndrome with a continuous-flow ventricular assist device: in vitro findings","volume":"59","author":"Dassanayaka","year":"2013","journal-title":"ASAIO J."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0160","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1161\/CIRCULATIONAHA.111.040246","article-title":"Bleeding and thrombosis in patients with continuous-flow ventricular assist devices","volume":"125","author":"Eckman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.thromres.2017.12.001","article-title":"Routine clinical antiplatelet agents have limited efficacy in modulating hypershear-mediated platelet activation associated with mechanical circulatory support","volume":"163","author":"Valerio","year":"2018","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0170","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/MAT.0b013e31817f3e03","article-title":"Mechanical circulatory device thrombosis: a new paradigm linking hypercoagulation and hypofibrinolysis","volume":"54","author":"Nielsen","year":"2008","journal-title":"ASAIO J."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0175","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1182\/blood.V79.1.38.38","article-title":"Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction","volume":"79","author":"Federici","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0180","doi-asserted-by":"crossref","first-page":"275280","DOI":"10.1182\/blood.V68.1.275.275","article-title":"Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation","volume":"68","author":"Stricker","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0185","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/01.CIR.0000016703.93845.AF","article-title":"Functional significance of adenosine 5\u2032-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate","volume":"105","author":"Goto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0190","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1160\/TH10-07-0439","article-title":"Shear-dependent suppression of platelet thrombus formation by phosphodiesterase 3 inhibition requires low levels of concomitant Gs-coupled receptor stimulation","volume":"105","author":"Yoshida","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2012.07.001","article-title":"Cilostazol down-regulates the height of mural platelet thrombi formed under a high-shear rate flow in the absence of ADAMTS13 activity","volume":"691","author":"Yagi","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0200","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2147\/VHRM.S3160","article-title":"Safety and efficacy of cilostazol in the management of intermittent claudication","volume":"4","author":"Chi","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"author":"FDA","key":"10.1016\/j.ijcha.2018.06.005_bb0205"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0210","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MBC.0b013e328136c19b","article-title":"Blood coagulation activation and fibrinolysis during a downhill marathon run","volume":"18","author":"Sumann","year":"2007","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0215","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(09)60243-9","article-title":"Aspirin, salicylates, and cancer","volume":"373","author":"Elwood","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1160\/TH06-05-0277","article-title":"Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression","volume":"97","author":"Feng","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0225","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archderm.143.8.1043","article-title":"Active angiogenesis in an extensive arteriovenous vascular malformation: a possible therapeutic target?","volume":"143","author":"Redondo","year":"2007","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0230","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/MBC.0b013e3282f1029c","article-title":"ABO blood group and bleeding after coronary artery bypass graft surgery","volume":"18","author":"Welsby","year":"2007","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0235","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12872-016-0334-z","article-title":"Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center","volume":"16","author":"Esmaeilzadeh","year":"2016","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0240","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.healun.2013.05.002","article-title":"Algorithm for the diagnosis and management of suspected pump thrombus","volume":"32","author":"Goldstein","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0250","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1161\/CIR.0b013e3182769a54","article-title":"Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association","volume":"126","author":"Peura","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0255","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/icvts\/ivs297","article-title":"What is the optimal anticoagulation in patients with a left ventricular assist device?","volume":"15","author":"Rossi","year":"2012","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0260","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/jth.12948","article-title":"Antithrombotic therapy for left ventricular assist devices in adults: a systematic review","volume":"13","author":"Baumann Kreuziger","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0265","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.healun.2013.11.010","article-title":"Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices","volume":"33","author":"Birschmann","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0270","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1610426","article-title":"A fully magnetically levitated circulatory pump for advanced heart failure","volume":"376","author":"Mehra","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0275","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/039139889501801016","article-title":"Control and treatment of hemostasis in cardiovascular surgery. The experience of La Piti\u00e9 Hospital with patients on total artificial heart","volume":"18","author":"Szefner","year":"1995","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0280","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jtcvs.2003.11.059","article-title":"Platelet activation and aggregation profile in prolonged external ventricular support","volume":"128","author":"Hou\u00ebl","year":"2004","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0285","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1067\/mtc.2001.111416","article-title":"Aspirin resistance after coronary artery bypass grafting","volume":"121","author":"Zimmerman","year":"2001","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0290","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0140-6736(99)00498-5","article-title":"Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance","volume":"353","author":"Weber","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0295","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1182\/blood.V74.6.2016.2016","article-title":"Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets","volume":"74","author":"Parker","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0300","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1345\/aph.1P459","article-title":"Pharmacotherapy for mechanical circulatory support: a comprehensive review","volume":"45","author":"Ensor","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0305","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/phar.1501","article-title":"Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic management","volume":"35","author":"Jennings","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0310","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/CIRCHEARTFAILURE.115.002096","article-title":"Platelet inhibition with ticagrelor for left ventricular assist device thrombosis","volume":"8","author":"Oliveira","year":"2015","journal-title":"Circ. Heart Fail."},{"issue":"221","key":"10.1016\/j.ijcha.2018.06.005_bb0315","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijcard.2016.06.304","article-title":"Ticagrelor for left ventricular assist device thrombosis: a new therapeutic option to be evaluated with caution","volume":"15","author":"Morici","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0320","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/MAT.0000000000000497","article-title":"Medical management of pump related thrombosis in patients with continuous flow left ventricular assist devices: a systematic review and metaanalysis","volume":"63","author":"Dang","year":"2017","journal-title":"ASIAO J."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0325","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.healun.2013.12.001","article-title":"An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial","volume":"33","author":"Najjar","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0330","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MAT.0000000000000028","article-title":"Left ventricular assist device pump thrombosis: is there a role for glycoprotein IIb\/IIIa inhibitors?","volume":"60","author":"Bellumkonda","year":"2014","journal-title":"ASAIO J."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0335","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.recesp.2011.02.005","article-title":"Bivalirudin as an anticoagulant during percutaneous coronary interventions in acute coronary syndromes: strengths and doubts","volume":"64","author":"Savonitto","year":"2011","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0340","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0345","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.jacc.2016.02.073","article-title":"Heparin-induced thrombocytopenia: a comprehensive clinical review","volume":"67","author":"Salter","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0350","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1345\/aph.1M179","article-title":"Prefilter bivalirudin for preventing hemofilter occlusion in continuous renal replacement therapy","volume":"43","author":"Mueller","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0355","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/aor.12168","article-title":"Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices","volume":"38","author":"Pieri","year":"2014","journal-title":"Artif. Organs"},{"key":"10.1016\/j.ijcha.2018.06.005_bb0360","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MAT.0000000000000317","article-title":"Comparison of anticoagulation strategies after left ventricular assist device implantation","volume":"62","author":"Kantorovich","year":"2016","journal-title":"ASAIO J."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0365","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MAT.0000000000000122","article-title":"Bivalirudin for treatment of LVAD thrombosis: a case series","volume":"60","author":"Sylvia","year":"2014","journal-title":"ASAIO J."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0370","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MAT.0000000000000067","article-title":"Argatroban as novel therapy for suspected thrombosis in patients with continuous-flow left ventricle assist device and hemolysis","volume":"60","author":"Badiye","year":"2014","journal-title":"ASAIO J."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0375","first-page":"20","article-title":"Dabigatran etexilate as second-line therapy in patients with a left ventricular assist device","volume":"56","author":"Terrovitis","year":"2015","journal-title":"Hell. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2018.06.005_bb0380","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003709","article-title":"Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: a randomized controlled pilot trial","volume":"10","author":"Andreas","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0385","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2018.06.005_bb0390","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N. Engl. J. Med."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235290671730060X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235290671730060X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T20:03:03Z","timestamp":1661544183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235290671730060X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":78,"alternative-id":["S235290671730060X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2018.06.005","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic therapy in ventricular assist device (VAD) management: From ancient beliefs to updated evidence. A narrative review","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}